Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hans Bruderer is active.

Publication


Featured researches published by Hans Bruderer.


Life Sciences | 1965

Two types of monoamine liberation by chlorinated aralkylamines

A. Pletscher; M. Da Prada; G. Bartholini; W. P. Burkard; Hans Bruderer

Abstract Two p-chlorinated aralkylamines (I and II) decrease the 5HT and NE in the brain of rats as well as the 5HT in platelets of rabbits and concomitantly increase 5-hydroxyindoleacetic acid and 5-hydroxytryptophol. The chemically related p-chloro-N, α-dimethylphenethylamine (III) causes, as previously described, a selective diminution of 5HT without increasing the 5HT metabolites. The two former drugs are about 10 times less potent than compound III in inhibiting the oxidative deamination of 5HT in vitro, but about 25 – 45 times more effective in liberating platelet 5HT. In the brain in vivo, III reaches higher levels than II. It is concluded that drug-induced differences in the rate of oxidative deamination of liberated 5HT might be responsible for the different metabolic pattern of the amine.


Tetrahedron | 1968

Synthesis in the emetine series—XIV : A new synthesis of 2,3,11-trisubstituted berbines

A. Brossi; Hans Bruderer; Albert Israel Rachlin; Sidney Teitel

Abstract A new synthesis of 2,3,11-trisubstituted berbines is described. By this method the dimethoxysubstituted benzoquinolizidine keto ester I is annealted with a four carbon unit, cyclized and aromatized in the presence of an alcohol to give the 2,3-dimethoxy-11-alkoxy-substituted berbines VIII, IX and X. The stereochemistry of the intermediate compounds has been elucidated by physical-chemical methods.


Helvetica Chimica Acta | 1989

Catechol-O-methyltransferase-Inhibiting Pyrocatechol Derivatives: Synthesis and Structure-Activity Studies

Janos Borgulya; Hans Bruderer; Karl Bernauer; Gerhard Zürcher; Mosé Da Prada


Journal of Pharmacology and Experimental Therapeutics | 1966

ARALKYLAMINES WITH DIFFERENT EFFECTS ON THE METABOLISM OF AROMATIC MONOAMINES

A. Pletscher; M. Da Prada; W. P. Burkard; G. Bartholini; F.A. Steiner; Hans Bruderer; F. Bigler


Archive | 1987

3,5-disubstituted pyrocatechol derivatives

Karl Bernauer; Janos Borgulya; Hans Bruderer; Prada. Mosé Prof. Dr. Da; Gerhard Zürcher


Archive | 1994

Oxazolidine-2-one derivatives as MAO inhibitors

Janos Borgulya; Hans Bruderer; Roland Jakob-Roetne; Stephan Röver


Helvetica Chimica Acta | 1967

Zur massenspektrometrischen Eliminierung von Neutralpartikeln aus Molekel‐ und Fragment‐Ionen

Hans Bruderer; W. Richter; Walter Vetter


Helvetica Chimica Acta | 1965

Synthesen in der Isochinolinreihe Zur partiellen Ätherspaltung 6,7‐dimethoxy‐substituierter 3,4‐Dihydro‐isochinoline und Isochinoline

Hans Bruderer; A. Brossi


Helvetica Chimica Acta | 1976

«Alkaloide» in tierischem und menschlichem Gewebe. 6. Mitteilung [1] [2]. Synthese und absolute Konfiguration chiraler 2, 3, 10, 11 ‐ Tetrahydroxy‐8‐methyl‐berbine [3]

Hans Bruderer; J. Metzger; A. Brossi; John J. Daly


Archive | 1981

Cyclohexene derivative analgesics

Hans Bruderer; Albert Fischli; Rudolf Pfister

Collaboration


Dive into the Hans Bruderer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge